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In the nervous system, neural stem cells (NSCs) are
necessary for the generation of new neurons and for
cognitive function. Here we show that FoxO3, a
member of a transcription factor family known to
extend lifespan in invertebrates, regulates the NSC
pool. We find that adult FoxO3/ mice have fewer
NSCs in vivo than wild-type counterparts. NSCs iso-
lated from adult FoxO3/ mice have decreased self-
renewal and an impaired ability to generate different
neural lineages. Identification of the FoxO3-depen-
dent gene expression profile in NSCs suggests that
FoxO3 regulates the NSC pool by inducing a program
of genes that preserves quiescence, prevents prema-
ture differentiation, and controls oxygen metabolism.
The ability of FoxO3 to prevent the premature deple-
tion of NSCs might have important implications for
counteracting brain aging in long-lived species.
INTRODUCTION
Neural stem cells (NSCs) can self-renew and generate all three
neural lineages of the nervous system: neurons, astrocytes,
and oligodendrocytes. During embryonic and postnatal develop-
ment, NSCs give rise to rapidly amplifying neural progenitors,
which are responsible for the proper formation of the nervous
system. The adult mammalian brain contains two residual popu-
lations of relatively quiescent NSCs in the subgranular zone
(SGZ) of the dentate gyrus (DG) in the hippocampus and in the
subventricular zone (SVZ) of the cortex (Alvarez-Buylla and
Temple, 1998; Zhao et al., 2008). In the adult brain, the genera-
tion of new neurons (neurogenesis) from NSCs is thought to
play an important role in learning and memory, spatial pattern
separation, and odor discrimination (Clelland et al., 2009; Gheusi
et al., 2000; Imayoshi et al., 2008). Both the number of NSCs and
neurogenesis decline with age and this age-dependent decline is
correlated with a gradual loss of cognitive and sensory functions
(Bondolfi et al., 2004; Kempermann et al., 1998; Tropepe et al.,
1997). Conversely, the pool of NSCs, neurogenesis, and cogni-Ctive performance in adults are preserved in a strain of long-lived
mutant mice (Kinney et al., 2001; Sun et al., 2005). Thus, an intact
pool of functional NSCs may be crucial for preserving cognitive
functions throughout life.
The polycomb family member Bmi-1 has been recently found
to play an important role in NSC self-renewal by negatively regu-
lating the cell cycle inhibitor p21CIP1 in embryonic NSCs (Fasano
et al., 2007), and p16INK4a and p19ARF in adult NSCs (Molofsky
et al., 2005, 2006). TLX, a nuclear receptor, also regulates NSC
self-renewal during development and adulthood in a cell-auton-
omous manner (Zhang et al., 2008). Other mechanisms to regu-
late the self-renewal and multipotency of NSCs throughout life
remain largely unknown, but one intriguing possibility is that
genes that regulate lifespan in invertebrates may have evolved
to control stem cell pools in mammals.
FoxO transcription factors are necessary for the extreme
longevity of mutants of the insulin pathway in invertebrates (Ken-
yon, 2005). In humans, single-nucleotide polymorphisms in one
of the four FoxO genes, FoxO3, have recently been associated
with extreme longevity (Flachsbart et al., 2009; Willcox et al.,
2008), raising the possibility that FoxO3 also regulates lifespan
in mammals. FoxO factors can elicit a variety of cellular
responses, including cell cycle arrest, differentiation, resistance
to oxidative stress, and apoptosis (Salih and Brunet, 2008). FoxO
factors have recently been found to regulate the self-renewal of
adult hematopoietic stem cells (HSCs), primarily by providing
resistance to oxidative stress (Miyamoto et al., 2007; Tothova
et al., 2007). Whether and how FoxO transcription factors regu-
late NSCs is unknown.
FoxO transcription factors are inactivated in response to
insulin or growth factors by phosphorylation by the protein
kinase Akt, which results in their nuclear export (Salih and
Brunet, 2008). Activation of the PI3K-Akt pathway, for example
by ablation of the gene encoding the PTEN phosphatase,
promotes the self-renewal of neural progenitor cells (Groszer
et al., 2006; Li et al., 2002; Sinor and Lillien, 2004). However,
the role of the PI3K-Akt pathway in the NSC pool in vivo has
not been examined and the PI3K-Akt pathway has many other
downstream targets in addition to FoxO factors.
Here we show that the transcription factor FoxO3, a member
of a gene family that extends lifespan in invertebrates, is neces-
sary for the regulation of the NSC pool in mice. We also identifyell Stem Cell 5, 527–539, November 6, 2009 ª2009 Elsevier Inc. 527
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suggest that FoxO3 regulates the NSC pool by inducing
a program that promotes quiescence, prevents premature differ-
entiation, and controls oxygen metabolism. FoxO3’s ability to
regulate NSC homeostasis may protect normal cognitive func-
tion in organisms that live to an advanced age.
RESULTS
FoxO3 Is Expressed in Adult NSCs/Neural Progenitors
In Vivo and In Vitro
To determine whether FoxO3 protein is expressed in NSC niches
in the adult mouse brain, we used an antibody that recognized
FoxO3 but did not significantly detect FoxO1, FoxO4, or
FoxO6 in cells (Figures S1A–S1C available online). We stained
brain sections of adult FoxO3+/+ and FoxO3/ mice with this
antibody and found that FoxO3 is expressed in both the SGZ
and the SVZ (Figure S2A). Western blotting experiments
confirmed that FoxO3 is highly expressed in NSC niches
in vivo (Figure S2B).
NSC niches contain NSCs, committed progenitors, and differ-
entiated progeny. To determine whether FoxO3 is expressed in
NSCs in vivo, we stained brain sections with antibodies to
FoxO3 and to Sox2, a marker of NSCs/neural progenitors, or
to NeuN, a marker of neurons (Figure 1A). These experiments re-
vealed that FoxO3 is expressed in Sox2-positive cells in the SGZ
and the SVZ (Figure 1A). FoxO3 is expressed in a subset of
NeuN-negative cells (Figure 1A, bottom, white arrows) and in
Fo
xO
3 
N
es
tin
Fo
xO
3
Whole NS
+/+ -/- FoxO3
FoxO3
β-actin
D
F
DifferentiationAge
+/+ -/- +/+ -/-
1d 3m 1y
FoxO3
FoxO3 T32-P
β-actin
0 1 2 3 4 5 6 days
FHRE pGL3
pGL3
***
N
or
m
al
iz
ed
 lu
cif
er
as
e
a
ct
iv
ity
E
- WT CA I - WT CA IFoxO3: FoxO3 +/+ FoxO3 -/-
FHRE pGL3
pGL3
***
***
**
*
***
**
N
or
m
al
iz
ed
 lu
cif
er
as
e
a
ct
iv
ity
8
6
4
2
0
5
4
3
2
1
0
A
D
A
PI
Fo
xO
3 
So
x2
Fo
xO
3
DG SVZ
C
Fo
xO
3 
N
eu
N
B
Diss. NSCs
Figure 1. FoxO3 Is Expressed and Active in
NSCs
(A) FoxO3 is expressed in adult NSCs in vivo.
Immunohistochemistry on brain sections of
3-month-old mice with antibodies to FoxO3
(‘‘Ct’’), Sox2, and NeuN in the dentate gyrus (DG)
of the hippocampus and in the subventricular
zone (SVZ) of Sox2-positive/FoxO3-positive
and NeuN-negative/FoxO3-positive nuclei are
shown by white arrowheads. Higher magnification
images are included. Scale bar represents
100 mm.
(B) FoxO3 is expressed in purified NSCs in culture.
Immunocytochemistry on NSCs isolated from
3-month-old mice with antibodies to FoxO3
(‘‘Ct’’) and to Nestin. DAPI was used to stain nuclei.
NSCs were either grown as neurospheres (whole
NS) (left) or freshly dissociated NSCs (Diss.
NSCs) (right). Scale bar represents 100 mm.
(C) FoxO3 expression in NSCs at different ages.
Western blots of protein lysates from second-
ary neurospheres in self-renewing conditions
from FoxO3+/+ and FoxO3/ littermates at three
different ages, 1-day-old (1d), 3-month-old (3m),
and 1-year-old (1y), probed with antibodies to
FoxO3 (‘‘NFL’’) and to b-actin. The data presented
are representative of three independent experi-
ments.
(D) FoxO3 phosphorylation is increased in differ-
entiated progeny. Western blots of protein lysates
of dissociated wild-type adult NSCs in self-renew-
ing conditions (day 0) or in differentiation condi-
tions for increasing lengths of time (days 1–6)
(Figure S3B). Western blots were probed with anti-
bodies to FoxO3 (‘‘NFL’’), to Phospho-T32 (FoxO3
T32-P) and to b-actin. Blots representative of three
independent experiments.
(E) A FoxO-dependent reporter gene is responsive
to FoxO3 in NSCs. Luciferase assays in wild-type
adult NSCs with a promoter containing three FoxO
binding sites driving the luciferase reporter gene
(FHRE pGL3) or a control promoter (pGL3) and
FoxO3 expression vectors (minus sign, empty
vector; WT, wild-type; CA, constitutively active; I,
inactive). Values represent mean ± SEM from three
independent experiments. One-way ANOVA, Bon-
ferroni posttests, *p < 0.05, **p < 0.01, ***p < 0.001.
(F) Endogenous FoxO3 is active in self-renewing NSCs. Luciferase assays in FoxO3+/+ and FoxO3/ adult NSCs with FHRE pGL3 or control pGL3 as in (E).
Values were normalized to the first column. Values represent mean ± SEM from three independent experiments. One-way ANOVA, Bonferroni posttests,
**p < 0.01, ***p < 0.001.528 Cell Stem Cell 5, 527–539, November 6, 2009 ª2009 Elsevier Inc.
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FoxO3 Regulates Neural Stem Cell Homeostasisbromodeoxyuridine (BrdU)-positive label-retaining cells, which
are thought to be NSCs (Figure S2C; see Figure 2). These results
indicate that FoxO3 is expressed in adult NSCs, as well as in
other cells in the NSC niches. The fact that FoxO3 staining over-
laps with the nuclear staining of Sox2 and BrdU further suggests
that FoxO3 is nuclear in adult NSCs and therefore likely to be
active in these cells (Figure 1A; Figure S2C).
To confirm that FoxO3 is expressed in NSCs, we isolated
NSCs from both the DG and the SVZ regions of the postnatal
or adult mouse brain. Mouse NSCs form clonal spheres called
neurospheres, which are composed of NSCs and more
committed neural progenitors (Reynolds and Weiss, 1992).
Immunostaining experiments on whole neurospheres or on
dissociated NSCs revealed that FoxO3 is expressed in
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Figure 2. The Ablation of FoxO3 Results in a Decrease in NSC Number In Vivo
(A) Experimental design for the quantification of NSCs in vivo. 5-month-old FoxO3+/+ and FoxO3/ littermates were injected daily with BrdU for 7 days and sacri-
ficed 1 month after the last BrdU injection.
(B) Quantification of label-retaining NSCs in vivo. Number of BrdU-positive cells 1 month after 7 days of daily BrdU injection in SGZ of the DG (left) and the SVZ
(right, Figure S4A). The number of BrdU-positive cells in the SGZ was normalized to the volume of the granular cell layer (GCL) (Figure S4C). Values represent
mean ± SEM (left) and mean ± SD (right) from five animals for FoxO3+/+ and four animals for FoxO3/ mice. Mann-Whitney test, *p < 0.05.
(C) Examples of label-retaining NSCs in the DG of FoxO3+/+ and FoxO3/ mice. Coronal sections of adult FoxO3+/+ and FoxO3/ mouse brains showing
BrdU-positive nuclei in the SGZ 1 month after 7 days of daily BrdU injection. Filled arrowhead: label-retaining NSCs. Empty arrowhead: BrdU-positive cells
that have migrated into the GCL. DG, dentate gyrus; H, hilus. Scale bar represents 200 mm. Right panels represent higher magnifications of the rectangles in
the left panels.
(D) Experimental design for the quantification of proliferating NSCs and neural progenitors in vivo. 5-month-old FoxO3+/+ and FoxO3/ littermates were injected
daily with BrdU for 7 days and sacrificed 1 day after the last BrdU injection.
(E) Quantification of proliferating NSCs and neural progenitors in vivo. Number of BrdU-positive cells in the SGZ (left) and in the SVZ (right) 1 day after 7 days of
daily BrdU injection. The number of BrdU-positive cells in the SGZ was normalized to the GCL volume (Figure S4D). Values represent mean ± SEM (left) and
mean ± SD (right) from three animals for each genotype. Mann-Whitney test, p = 0.40 (left) and p = 0.10 (right).
(F) Brain weight is increased in adult FoxO3/ mice compared to FoxO3+/+ littermates. Brain weights were measured for FoxO3/ and FoxO3+/+ animals in mice
at different ages (1-day-old [1d], 3-month-old [3m], and 1-year-old [1y]). Values represent mean ± SEM from 4–6 mice (1d), 20–23 males and 6–9 females (3m),
and 4–7 males and females (1y). Mann-Whitney test, *p < 0.05; **p < 0.01; ***p < 0.001.Cell Stem Cell 5, 527–539, November 6, 2009 ª2009 Elsevier Inc. 529
Cell Stem Cell
FoxO3 Regulates Neural Stem Cell HomeostasisNSCs/progenitors derived from both postnatal and adult animals
and is coexpressed with Nestin, a NSC/progenitor marker (Fig-
ure 1B; Figure S3A).
To quantify the levels of FoxO3 in NSCs as a function of age,
we used western blotting on protein extracts of neurospheres
from NSCs isolated from mice at three different age milestones:
birth (1-day-old), adulthood (3-month-old), and middle age
(1-year-old). These experiments confirmed that FoxO3 is ex-
pressed in NSCs from mice at all ages (Figure 1C). FoxO3
protein expression is lower in NSCs from neonates than in
NSCs from adults, but there was no significant change in
FoxO3 expression in NSCs from young versus middle-aged
adults (Figure 1C). Thus, FoxO3 is expressed in NSCs/progeni-
tors from both developing and adult mice, with higher expres-
sion in adult NSCs.
FoxO3 Activity Is Higher in Self-Renewing NSCs than
in Differentiated Progeny
To assess FoxO3 activity in NSCs, we compared the phosphor-
ylation status of FoxO3 in self-renewing versus differentiating
adult NSCs via western blotting with phospho-specific anti-
bodies to Threonine 32 (T32), one of the three sites of FoxO3
phosphorylated by Akt (Brunet et al., 1999). A larger percentage
of FoxO3 was phosphorylated at T32 in differentiated progeny
than in self-renewing NSCs (Figure 1D; Figure S3B). As T32
phosphorylation is correlated with FoxO3 inactivation (Brunet
et al., 1999), these results suggest that FoxO3 is more active in
self-renewing NSCs than in their differentiated progeny.
To quantify FoxO3 activity in NSCs, we performed luciferase
assays by using a luciferase reporter gene under the control of
three Forkhead binding sites (Brunet et al., 1999). We first veri-
fied that this FoxO reporter gene was responsive to FoxO3 in
NSCs by transfecting wild-type adult NSCs with active or inac-
tive forms of FoxO3 (Figure 1E). We next tested the activity of
endogenous FoxO3 in NSCs and found that this FoxO reporter
gene was active in adult FoxO3+/+ NSCs and that its activity
was significantly decreased in FoxO3/ NSCs (Figure 1F).
The remainder of the activity of the FoxO reporter gene in
FoxO3/ NSCs is likely due to partial compensation by other
FoxO family members. Taken together, these findings indicate
that FoxO3 is active in self-renewing NSCs.
The Ablation of FoxO3 Results in a Decrease in NSC
Number In Vivo
To determine whether FoxO3 regulates the NSC pool in vivo, we
performed BrdU injection experiments in adult FoxO3/ and
FoxO3+/+ mice (Figure 2). FoxO3/ mice are viable and normal
in outward appearance, though they are prone to cancer and
die at around 1 to 1.5 years of age (data not shown; Paik et al.,
2007). BrdU was injected daily into adult FoxO3/ and
FoxO3+/+ littermates for 7 days and the mice were sacrificed
either 1 month (Figure 2A) or 1 day (Figure 2D) after the last
BrdU injection. We counted BrdU-positive cells in the NSC
niches 1 month after the last BrdU injection (Figures 2B and 2C;
Figure S4A). These label-retaining cells are thought to be the
relatively quiescent NSCs that remain in NSC niches whereas
neural progenitors and differentiated cells migrate away from
NSC niches (Bondolfi et al., 2004). FoxO3/ mice displayed
a significant reduction in the number of label-retaining NSCs530 Cell Stem Cell 5, 527–539, November 6, 2009 ª2009 Elsevier Incompared to FoxO3+/+ mice in both the SGZ (Figure 2B, left)
and the SVZ (Figures 2B, right, and Figure S4A). This result
suggests that in the absence of FoxO3, adult mice have fewer
NSCs. In contrast, when mice were sacrificed 1 day after the
BrdU injections (Figure 2D), FoxO3/ mice tended to have
more BrdU-positive cells than FoxO3+/+ mice in the SGZ (p =
0.40) and the SVZ (p = 0.10) (Figure 2E). BrdU-positive cells in
the short-term BrdU paradigm are mostly neural progenitors,
so these results indicate that in FoxO3/ mice, the number of
progenitors is not decreased and may even be slightly increased.
Consistent with this finding, brains from adult FoxO3/ mice
were significantly heavier than brains from wild-type counter-
parts. In contrast, brains from FoxO3/ mice had similar weight
as wild-type counterparts at birth (Figure 2F). Together, these
results suggest that FoxO3 loss may lead to the short-term
amplification of progenitors, resulting in the exhaustion of the
NSC pool over time.
The Absence of FoxO3 Leads to the Depletion
of NSCs in Adult Mice
To independently test whether FoxO3 prevents the progressive
depletion of NSCs in vivo, we isolated NSCs from adult
FoxO3/ and FoxO3+/+ mice and tested the ability of these cells
to form primary neurospheres. The frequency of primary neuro-
spheres formed at low cell density from freshly isolated NSCs
can be used as an estimate of the pool size of NSCs in the brain
and indirectly as a measure of self-renewal (Kippin et al., 2005).
We found that NSCs from adult FoxO3/ mice formed primary
neurospheres at a significantly lower frequency than NSCs from
FoxO3+/+ littermates (Figure 3A). Although neurospheres can
fuse, which can limit the interpretation of these experiments
(Reynolds and Rietze, 2005), these results confirm that FoxO3
regulates the NSC pool. These findings are also consistent with
the possibility that FoxO3 is necessary for NSC self-renewal.
To compare the ability of FoxO3 to regulate the NSC pool at
different ages, we isolated NSCs from FoxO3/ and FoxO3+/+
mice at different ages. FoxO3/ NSCs isolated from embryos
(data not shown) or from 1-day-old mice (Figure 3B; Figure S5A)
formed primary neurospheres with the same frequency as
FoxO3+/+ NSCs. In contrast, FoxO3/ NSCs isolated from
both young adult mice and middle-aged mice formed neuro-
spheres at a significantly lower frequency than FoxO3+/+ NSCs
(Figure 3B; Figure S5B). These results indicate that the absence
of FoxO3 leads to defects in the NSC pool that are evident only in
adult mice. Because FoxO3 is constitutively deleted in FoxO3/
mice, it is not possible to distinguish whether FoxO3 regulates
the NSC pool only in adults or whether FoxO3 also acts in
NSCs during embryonic and/or postnatal development. As
previously reported (Molofsky et al., 2006), the frequency of
primary neurospheres formed in culture decreased significantly
with the age of the mice (Figure 3B). The absence of FoxO3
did not have a greater impact on NSCs from middle-aged
mice than in NSCs from young adult mice (Figure 3B), which
might be due to a progressive inactivation of FoxO3 function
during aging.
FoxO3 Is Necessary for NSC Self-Renewal
We tested whether FoxO3 is necessary for NSC self-renewal.
Primary neurospheres can be dissociated to generate secondaryc.
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Figure 3. FoxO3 Regulates the NSC Pool and NSC Self-Renewal in
Adult Mice, but Not in Neonates
(A) FoxO3/ NSCs from adult mice display a defect in primary neurosphere
formation. NSCs isolated from 3-month-old FoxO3+/+ or FoxO3/ littermates
were seeded at the indicated cell densities. The number of neurospheres
formed after 1 week was counted. Values represent mean ± SEM from seven
independent experiments performed with five littermates for each genotype.
Two-way ANOVA (p < 0.0001 for the genotype variable), Bonferroni posttests,
***p < 0.001.
(B) FoxO3/ NSCs from adult mice, but not from neonates, display a defect in
primary neurosphere formation. Frequency of primary neurospheres formed
from NSCs at low density (8000 cells/ml) from mice at different ages (1-day-
old [1d], 3-month-old [3m], 1-year-old [1y]). Values represent mean ± SEM
from two independent experiments with two littermates (1d), seven indepen-
dent experiments with five littermates (3m), and three independent experi-
ments with three to five littermates (1y) for each genotype. Two-way ANOVA
with Bonferroni posttests, *p < 0.05; ***p < 0.001.
(C) FoxO3/ NSCs from adult mice, but not from neonates, display a defect in
secondary neurosphere formation. Dissociated cells from primary neuro-
spheres from FoxO3+/+ or FoxO3/ littermates were seeded at 4000 cells/
ml. The number of secondary neurospheres formed after 1 week was counted.
Values represent mean ± SEM from two independent experiments with twoCneurospheres, and the number of secondary neurospheres
formed can serve as a measure of NSC self-renewal (Kippin
et al., 2005). We dissociated FoxO3/ and FoxO3+/+ primary
neurospheres and tested the ability of the dissociated cells to
form secondary neurospheres. Whereas FoxO3/ NSCs from
neonates formed secondary neurospheres at the same
frequency as FoxO3+/+ NSCs, FoxO3/ NSCs isolated from
young and middle-aged adults generated fewer secondary neu-
rospheres than FoxO3+/+ NSCs (Figure 3C; Figures S5C–S5E).
This result suggests that FoxO3 regulates NSC self-renewal.
The ability of adult FoxO3/ NSCs to form neurospheres at later
passages in vitro was not significantly different from that of
FoxO3+/+ NSCs (Figure S5F), perhaps because other FoxO
family members compensate for the lack of FoxO3 after several
passages in culture. Concomitant deletion of FoxO1, FoxO3, and
FoxO4 results in defects in neurosphere formation upon serial
passage in culture (Paik et al., 2009 [this issue]), confirming the
functional redundancy among FoxO family members in cultured
NSCs. These results suggest that FoxO3 prevents the premature
exhaustion of NSCs by preserving their self-renewal capacity.
The Ability of NSCs to Generate Different Neural
Lineages Is Defective in the Absence of FoxO3
NSCs give rise to three types of progeny (neurons, astrocytes,
and oligodendrocytes), and the proper balance between the
three fates is pivotal for the functionality of the NSC pool. The
ability of NSCs to generate progeny can be measured by assess-
ing cellular fates in secondary neurospheres, because each neu-
rosphere derives from a single NSC (Kippin et al., 2005). We
examined the progeny of FoxO3/ and FoxO3+/+ secondary
neurospheres after 7 days in differentiation conditions. Neuro-
spheres generated from adult NSCs contained mainly astrocytes
(GFAP positive), as well as fewer numbers of immature neurons
(Tuj1 positive) or immature oligodendrocytes (O4 positive)
(Figure 4A), indicating that these neurospheres arose from at
least bipotent NSCs. To measure NSC functionality, we scored
the number of differentiated secondary neurospheres formed at
low cell density that contain at least one immature neuron (Tuj1
positive) or one immature oligodendrocyte (O4 positive) in addi-
tion to astrocytes. We found that NSCs isolated from neonate
FoxO3/ and FoxO3+/+ mice formed similar numbers of bipo-
tent neurospheres (Figures 4B and 4C). In contrast, NSCs
isolated from young or middle-aged adult FoxO3/ mice
formed significantly fewer secondary neurospheres containing
oligodendrocytes than those isolated from FoxO3+/+ mice
(Figure 4B). FoxO3/ NSCs from middle-aged mice tended to
form fewer neurospheres containing both neurons and astro-
cytes and more neurospheres containing only astrocytes
compared to FoxO3+/+ NSCs (Figures 4C and 4D). Similar results
were obtained when differentiated neurospheres were stained
for all three cell fates simultaneously (Figure S6). These findings
indicate that FoxO3 loss results in a deficiency in the ability of
NSCs to generate different neural lineages that is evident only
in adulthood. Our observations further suggest that in the
littermates (1d), four independent experiments with five littermates (3m), and
four independent experiments with three to five littermates for each genotype
(1y) for each genotype. Two-way ANOVA with Bonferroni posttests, *p < 0.05.ell Stem Cell 5, 527–539, November 6, 2009 ª2009 Elsevier Inc. 531
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Figure 4. FoxO3Controls theAbility of Adult
NSCs to Give Rise to Different Lineages
(A) Adult NSCs give rise to at least bipotent neuro-
spheres. Astrocytes, neurons, and oligodendro-
cytes present in whole neurospheres after 7 days
of differentiation were stained with antibodies to
GFAP, Tuj1, and O4, respectively. Scale bars
represent 100 mm.
(B) FoxO3/ NSCs from adult mice, but not from
neonates, give rise to fewer oligodendrocyte-
containing neurospheres than FoxO3+/+ NSCs.
FoxO3+/+ and FoxO3/ NSCs from mice at
different ages (1-day-old [1d], 3-month-old [3m],
1-year-old [1y]) were grown as secondary neuro-
spheres at low density. The neurospheres were
differentiated for a week and stained with anti-
bodies to O4. Neurospheres that contained oligo-
dendrocytes were counted. Values represent
mean ± SEM from two independent experiments
with two littermates (1d), five littermates (3m),
and three to five littermates (1y) for each genotype.
Student’s t test, *p < 0.05; **p < 0.01.
(C and D) FoxO3/ NSCs from middle-aged mice
tend to give rise to fewer neuron-containing neuro-
spheres than FoxO3+/+ NSCs. Neurospheres were
grown as described in (B) and stained with anti-
bodies to Tuj1 and GFAP. Neurospheres that con-
tained neurons and astrocytes were counted.
Values represent mean ± SEM from two indepen-
dent experiments with two littermates (1d), five
littermates (3m), and three to five littermates (1y)
for each genotype. Student’s t test, p = 0.18.
(C) Neurospheres containing at least one Tuj-
1-positive cell.
(D) Neurospheres containing only GFAP-positive
cells.absence of FoxO3, NSCs become more similar to progenitors
(i.e., less able to self-renew and more committed to a specific
lineage). NSCs lacking FoxO3 also resemble NSCs from older
animals, which are less able to self-renew and more skewed
toward astrocytes (Bondolfi et al., 2004).
FoxO3 Acts in the Nervous System to Regulate
the NSC Pool
FoxO3 is expressed in a number of tissues, raising the question
of whether FoxO3 regulates the NSC pool by acting in the brain
or in other tissues, which could in turn affect NSCs. To address
this question, we crossed FoxO3lox/lox mice with Nestin-Cre
transgenic mice, which express the Cre recombinase in NSCs/
progenitors from embryonic day 10.5 (Tronche et al., 1999). As
expected, FoxO3lox/lox;Nestin-Cre mice displayed an ablation
of the FoxO3 protein in the brain, but not in the majority of other
tissues (Figure 5A). Interestingly, young and middle-aged adult
FoxO3lox/lox;Nestin-Cre mice had significantly heavier brains
than their control siblings (Figure 5B). These results suggest
that FoxO3 regulates brain weight by acting in the nervous
system, rather than in other tissues.
To test whether FoxO3 regulates the NSC pool by acting in the
nervous system, we performed BrdU long-term retention exper-
iments in vivo in FoxO3lox/lox;Nestin-Cre mice and FoxO3lox/lox
siblings (Figure 5C). We found that young adult FoxO3lox/lox;
Nestin-Cre mice tended to have fewer label-retaining NSCs in532 Cell Stem Cell 5, 527–539, November 6, 2009 ª2009 Elsevier Inthe SVZ and in the SGZ than control siblings, though this
did not reach statistical significance (Figure 5C). The effects
of FoxO3 loss in vivo were less pronounced in FoxO3lox/lox;
Nestin-Cre mice than in FoxO3/ mice, which could suggest
that FoxO3 regulates NSCs in part by acting in tissues other
than the nervous system. However, the difference in magnitude
in long-term BrdU retention between FoxO3lox/lox;Nestin-Cre and
FoxO3/ mice is likely due to the different genetic backgrounds
of these mice and/or to the different ages of the mice when the
NSC pools were examined.
To independently test whether FoxO3 acts in the nervous
system to regulate NSCs, we isolated NSCs from FoxO3lox/lox;
Nestin-Cre mice and control mice and assessed their ability to
form primary neurospheres. NSCs isolated from FoxO3lox/lox;
Nestin-Cre mice had no FoxO3 protein expression for up to
four passages (Figure 5D), indicating that the deletion of the
FoxO3 gene was efficient. Interestingly, NSCs isolated from
9-month-old FoxO3lox/lox;Nestin-Cre mice displayed significant
defects in their ability to form primary neurospheres compared
to NSCs isolated from control FoxO3lox/lox littermates
(Figure 5E). Together, these results suggest that FoxO3 acts in
the nervous system to regulate adult brain weight and NSC
homeostasis in vivo. Because FoxO3 is deleted from embryonic
day 10.5 in FoxO3lox/lox;Nestin-Cre mice, the effects of FoxO3
loss on brain weight and NSCs may be a result of FoxO3’s action
in the embryonic and/or postnatal brain. It is also possible thatc.
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blood vessels that form the NSC niche or metabolic tissues
that would then affect the systemic milieu. However, two inde-
pendent ways of deleting FoxO factors in the nervous
system—Nestin-Cre (this study) or GFAP-cre (Paik et al., 2009
[this issue])—both result in similar NSC phenotypes, supporting
the notion that FoxO factors act in the nervous system to regu-
late NSCs.
FoxO3 Regulates the Quiescence and Survival of NSCs
To determine the cellular mechanisms by which FoxO3 regulates
NSCs, we tested whether the absence of FoxO3 affects cell
proliferation in neurospheres. Cells dissociated from secondary
neurospheres from young adult FoxO3/ mice displayed
a significant increase in BrdU incorporation in culture compared
to cells from FoxO3+/+ mice (Figure 6A). There was no difference
in the proportion of cells in G2/M phases between FoxO3+/+ and
FoxO3/ NSCs (data not shown), suggesting that the primary
effect of FoxO3 loss is at the G1/S transition. Thus, the absence
of FoxO3 leads to the proliferation of NSCs/progenitors cells in
neurospheres. Without FoxO3, NSCs may lose their ability to
re-enter a state of relative quiescence after they divide, which
may lead to the amplification of progenitors and the exhaustion
of the pool of NSCs in vivo.
We also quantified apoptotic cell death in FoxO3/ and
FoxO3+/+ NSCs. Freshly isolated NSCs from adult FoxO3/
mice displayed an increased number of cleaved caspase 3-posi-
tive cells compared to FoxO3+/+ NSCs (Figure 6B, left), which
might contribute to the decreased self-renewal of FoxO3/
NSCs. In contrast, the level of apoptosis for cells dissociated
from secondary FoxO3/ neurospheres was lower than for cells
dissociated from FoxO3+/+ neurospheres (Figure 6B, right).
These findings, coupled with the observation that FoxO3/
mice have increased brain weight compared to FoxO3+/+ litter-
mates (Figure 2F), suggests that cell death is not a major conse-
quence of FoxO3 loss and that loss of quiescence may play
a more important role in the depletion of NSCs in vivo in
FoxO3/ mice.
FoxO3 Coordinates the Expression of a Specific
Program of Genes in NSCs
To gain insight into the molecular mechanisms by which FoxO3
regulates NSCs, we determined the program of genes regulated
by FoxO3 in NSCs. We performed a genome-wide microarray
analysis on RNA isolated from two independent biological repli-
cates, each in duplicate, of FoxO3/ and FoxO3+/+ secondary
neurospheres from young adult mice. We used secondary neu-
rospheres because FoxO3/ and FoxO3+/+ neurospheres dis-
played a significant difference in self-renewal ability. Analysis
of the microarray data revealed that the expression of a specific
subset of genes is decreased in FoxO3/ neurospheres
compared to FoxO3+/+ neurospheres (Figures 7A and 7B; Table
S1). The changes in expression levels of a number of these genes
were validated by reverse transcription followed by quantitative
PCR (Figure S7).
The analysis of our microarray data revealed that FoxO3 is
required for the expression of genes involved in cell quiescence,
as was previously shown in other cell types (Salih and Brunet,
2008). For example, FoxO3 is necessary for the expression ofCep27KIP1 and Cyclin G2 (Figure 7A; Figure S7). The comparison
of our microarray data with available molecular signatures re-
vealed that FoxO3-regulated genes were significantly enriched
for genes that form a molecular signature for quiescence (Fig-
ure 7C; Figures S8A and S8B). These results support the notion
that FoxO3 regulates the homeostasis of the NSC pool by pre-
venting the premature overproliferation of progenitors and
preserving the relative quiescence of NSCs. We also found
that FoxO3 was necessary for the expression of genes involved
in oxidative stress resistance (e.g., selenbp1) (Figure 7A;
Figure S7) and in glucose metabolism and transport (e.g.,
Pdk1, Slc2a3) (Figures 7A and 7C; Figure S7), consistent with
the known role of the FoxO family in stress resistance and
cellular metabolism (Accili and Arden, 2004). The ability of
FoxO3 to coordinate a program maintaining quiescence, stress
resistance, and glucose metabolism in adult NSCs may be
critical for preserving the stemness of these cells.
Interestingly, we also identified genes that were not previously
known to be upregulated by FoxO factors. First, FoxO3 was
necessary for the upregulation of genes involved in early neuro-
genesis (e.g., Otx2) (Figure 7A; Figure S7), which may contribute
to the defect in multipotency of FoxO3/ neurospheres (Fig-
ure S6). Surprisingly, the comparison between our microarray
data and publicly available molecular signatures revealed that
FoxO3 was necessary for the expression of genes upregulated
in hypoxic brains and other hypoxic tissues, including Ddit4,
Ndrg1, Ero1l, and Vegfa (Figures 7A and 7C; Figures S7, S8C,
and S8D; Table S1). These findings raise the possibility that
FoxO3 is necessary for the response of NSCs to low oxygen.
The ability of FoxO3 to control oxygen metabolism in NSCs
may participate in the regulation of NSCs in vivo.
FoxO3 is also required for the repression of specific genes in
neurospheres (Figure 7B). For example, genes expressed in
mature oligodendrocytes, including Myelin Basic Protein, Plp1,
and Apod, were upregulated in FoxO3/ NSCs compared to
FoxO3+/+ NSCs (Figure 7B; Figure S7; Table S1). These results
suggest that FoxO3 normally prevents premature oligodendro-
cyte differentiation. Consistent with these findings, we observed
that the corpus callosum area, a brain structure that contains
mature oligodendrocytes, is increased in adult FoxO3/ mice
compared to FoxO3+/+ littermates (Figure S9). The inhibition of
the premature differentiation of NSCs by FoxO3 may contribute
to the functionality of NSCs in vivo.
Finally, the comparison of our microarray data with genes that
are known to change during aging in human and mouse brains
revealed a correlation between FoxO3-regulated genes and
genes that are regulated during aging in the brain (Figure 7C;
Figures S8E and S8F). These observations are consistent with
the possibility that FoxO3, a gene that belongs to a family that
promotes longevity in invertebrates, also regulates genes that
are important to counteract the aging process in mammalian
adult stem cells.
Identification of FoxO3 Direct Targets in NSCs
FoxO3-regulated genes are enriched for the presence of a FoxO
binding motif in their regulatory regions (Figure 7A; Table S1),
raising the possibility that a subset of FoxO3-regulated genes
might be direct FoxO3 target genes in NSCs. To identify direct
targets of FoxO3, we performed electrophoretic mobility shiftll Stem Cell 5, 527–539, November 6, 2009 ª2009 Elsevier Inc. 533
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Figure 5. Consequences of FoxO3 Loss in the Nervous System on Brain Weight and the NSC Pool
(A) Expression of FoxO3 in the tissues of FoxO3lox/lox;Nestin-Cre mice. FoxO3 expression in different tissues of 2-month-old FoxO3lox/lox;Nestin-Cre mice was
determined by western blot with antibodies to FoxO3 (‘‘NFL’’) and antibodies to b-actin and karyopherin b. Note that FoxO3 was partially deleted in the pancreas.
(B) Brain weights of FoxO3lox/lox;Nestin-Cre and FoxO3lox/lox mice. Brain weights were measured after perfusion in 3- to 4-month-old mice (3–4m) and 1.6-year-old
mice (1.6y). Values represent mean ± SEM from nine to ten males and nine to ten females (3–4m), and one to three males and five to eight females (1.6y). One male
and two females (3–4m) and three females (1.6y) of the FoxO3lox/+ genotype were included in the control group (FoxO3lox/lox).
(C) Quantification of label-retaining NSCs in FoxO3lox/lox;Nestin-Cre and FoxO3lox/lox animals in vivo. Number of BrdU-positive cells in the SGZ (left) and the SVZ
(right) in 3-month-old FoxO3lox/lox;Nestin-Cre and FoxO3lox/lox littermates injected daily with BrdU for 7 days and sacrificed 1 month after the last BrdU injection.
The number of BrdU-positive cells in the SGZ was normalized to the volume of the granular cell layer (GCL). Values represent mean ± SEM (left) and mean ± SD
(right) from 8 FoxO3lox/lox;Nestin-Cre mice and 11 FoxO3lox/lox control littermates. Two FoxO3lox/+ littermates were included in the control group (FoxO3lox/lox).
Mann-Whitney test, p = 0.27 (left) and p = 0.14 (right).
(D) Ablation of the FoxO3 protein in NSCs from FoxO3lox/lox;Nestin-Cre mice. FoxO3 expression in NSCs isolated from 3-month-old FoxO3lox/lox mice () or
FoxO3lox/lox;Nestin-Cre mice (+) 7 days after isolation (NS1) or at three consecutive passages (NS2 to 4) was determined by western blot with antibodies to
FoxO3 (‘‘NFL’’) and antibodies to b-actin.
(E) Ablation of FoxO3 in the brain impairs primary neurosphere formation. NSCs isolated from 9-month-old FoxO3lox/lox mice (control) or FoxO3lox/lox;Nestin-Cre
mice were seeded at low density. The number of neurospheres formed after 1 week was counted. Values represent mean ± SEM from triplicates from four inde-
pendent experiments conducted with three littermates for each genotype. Two-way ANOVA, p < 0.01 for the genotype variable, Bonferroni posttests, **p < 0.01.534 Cell Stem Cell 5, 527–539, November 6, 2009 ª2009 Elsevier Inc.
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Figure 6. FoxO3 Is Necessary for Maintaining
NSCs/Neural Progenitor Quiescence
(A) Increased cell proliferation in FoxO3/ neurospheres.
Cells dissociated from secondary neurospheres from
3-month-old FoxO3+/+ or FoxO3/ mice were plated on
poly-D-lysine and incubated for 1 hr with BrdU. Cells
were immunostained with antibodies to BrdU. BrdU-posi-
tive nuclei were counted. Values represent mean ± SEM
from two independent experiments with five littermates
for each genotype. Student’s t test, ***p < 0.001.
(B) Apoptosis in FoxO3/ NSCs compared to FoxO3+/+
NSCs. Freshly isolated NSCs or cells dissociated from
secondary neurospheres isolated from 3-month-old
FoxO3+/+ or FoxO3/ mice were stained with antibodies
to cleaved caspase 3. Cleaved caspase 3-positive cells
were counted. Values represent mean ± SEM from two
independent experiments with five littermates for each
genotype. Student’s t test, **p < 0.01.assays (EMSA) and chromatin immunoprecipitation (ChIP) in
NSCs. EMSA experiments revealed that FoxO3 could bind
in vitro to FoxO binding sites present in the regulatory regions of
the Ddit4, Ndrg1, and Otx2, suggesting that these genes are
direct targets of FoxO3 (Figures S10A and S10B). ChIP experi-
ments revealed that FoxO3 is recruited to the FoxO binding sites
in the promoters of the p27KIP1 and Ddit4 genes (Figure 7D;
Figure S10C). These results indicate that p27KIP1, a cell cycle
inhibitor involved in cell quiescence and Ddit4, a known target
of hypoxia-inducible factor 1 (HIF1), are direct target genes of
FoxO3 in NSCs. In contrast, FoxO3 was not bound at the
promoters ofOtx2 andNdrg1 by ChIP (data not shown), suggest-
ing that these two genesmay notbe direct FoxO3 targets inNSCs.
The Response of FoxO3/ NSCs to Low Oxygen Is
Impaired In Vitro
Because a subset of FoxO3-regulated genes is involved in the
cellular response to hypoxia, we compared the ability of
FoxO3+/+ and FoxO3/ NSCs to form neurospheres in low-
oxygen (2%) versus atmospheric oxygen (20%) conditions
(Figure 7E). Consistent with published findings for embryonic
NSCs/progenitors (Studer et al., 2000), adult NSCs showed an
increased ability to form neurospheres in low oxygen compared
to atmospheric oxygen (Figure 7E). In contrast, FoxO3/ NSCs
did not display an increased ability to form neurospheres in low-
oxygen compared to atmospheric oxygen conditions (Figure 7E).
These results suggest that the response of FoxO3/ NSCs to
low oxygen is impaired in vitro. It is also possible that 2%
oxygen, which mimics in vivo physiological oxygen concentra-
tions in the mammalian brain (Zhu et al., 2005), helps reveal
differences between FoxO3/ and FoxO3+/+ NSCs. Together,
these results indicate that FoxO3 is necessary for the expression
of a program of genes that coordinate cell quiescence, inhibition
of premature differentiation, and oxygen metabolism, which may
all contribute to the ability of FoxO3 to regulate the homeostasis
of the NSC pool.
DISCUSSION
Our results indicate that FoxO3 regulates processes and path-
ways relevant to NSC homeostasis both in vitro and in vivo. InCthe absence of FoxO3, NSCs display a decreased ability to
self-renew and to give rise to different neural lineages, which
may result in the depletion of NSCs in vivo. Our findings also
suggest that FoxO3 regulates NSC homeostasis by controlling
a program of genes that precisely governs cell cycle re-entry
and promotes a state of glucose and oxygen metabolism
compatible with optimal self-renewal. Because the NSC pool is
a limited reserve that needs to be maintained throughout life,
preserving this pool may be an important factor in the healthspan
of long-lived organisms.
The effects of FoxO3 loss on NSCs manifest themselves only
in adult animals. This observation raises the possibility that
FoxO3 plays a more important role in adult NSCs than in embry-
onic or neonatal NSCs. It is also possible that FoxO3 acts to alter
embryonic or postnatal NSC biology or the NSC niche, which
would ultimately result in the depletion of adult NSCs later in
life. Alternatively, FoxO3 loss may be better compensated by
other FoxO family members in embryonic and postnatal NSCs
than in adult NSCs. Precisely studying the timing of action of
FoxO3 in NSCs will require crossing FoxO3lox/lox mice with
mice expressing a tamoxifen-inducible form of Cre (CreER)
driven from promoters that are active in NSCs, such as Nestin,
GFAP, Glast, or TLX (Johnson et al., 2009).
Our experiments indicate that FoxO3 exerts at least part of its
action in the nervous system to regulate brain weight and the NSC
pool. FoxO3 may also act in part in the stem cell niche or system-
ically to regulate NSCs. FoxO3 is expressed in neurons, astro-
cytes, and oligodendrocytes, as well as in endothelial cells of
the vasculature, all of which may contribute to the NSC niche.
Because FoxO3 has been shown to play an important role in
specific endothelial cells (Paik et al., 2007), a portion of the defect
observed in the brain of FoxO3/ mice might come from FoxO3
loss in blood vessels. A rigorous demonstration of the cell
autonomy of FoxO3 will require the generation of mouse models
in which FoxO3 is specifically deleted in NSCs. Nevertheless, the
observation that FoxO3lox/lox;Nestin-Cre mice (this study) and
FoxO1/3/4lox/lox;GFAP-Cre mice (Paik et al., 2009 [this issue]),
which both lead to FoxO deletion in NSCs, have similar NSC
phenotypes both in vivo and in vitro, suggests that FoxO factors
act cell autonomously in NSCs. This notion is further supported
by the observation that in vitro deletion of FoxO in NSCs leadsell Stem Cell 5, 527–539, November 6, 2009 ª2009 Elsevier Inc. 535
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Figure 7. FoxO3 Is Necessary for the Expression of a Program of Genes that Coordinately Regulates NSC Homeostasis
(A and B) Differentially regulated genes in FoxO3/ NSCs compared to FoxO3+/+ NSCs. Whole-genome microarray data obtained from two independent bio-
logical replicates of RNA from duplicates of FoxO3/ and FoxO3+/+ secondary neurospheres isolated from 3-month-old mice (five littermates for each genotype).
Heat-map of selected genes downregulated (A) and upregulated (B) more than 1.5-fold in FoxO3/NSCs compared to FoxO3+/+ NSCs with a false discovery rate
less than 5%. Lanes 1–2 and 5–6: duplicates from one experiment. Lanes 3–4 and 7–8: duplicates from a second independent experiment. Underlined: known
FoxO target genes. Surrounded by a square: genes containing FoxO binding motifs in their regulatory regions (Table S1).
(C) FoxO3-regulated genes in NSCs are involved in quiescence, hypoxia, aging, and glucose metabolism. Selected publicly available molecular signatures
highly enriched for genes downregulated in FoxO3/ NSCs as provided by GSEA (gene set enrichment analysis). See Supplemental Data for references
(Ref.) 1–12.
(D) FoxO3 is recruited to the promoters of p27KIP1 and Ddit4 in NSCs. ChIP of FoxO3 from NSCs isolated from 3-month-old mice shows significant recruitment of
FoxO3 at the promoters of p27KIP1 and Ddit4. FoxO3 recruitment was not found at control regions that did not have FoxO binding sites () and did not occur in
FoxO3/ neurospheres. Depicted is a representative ChIP analysis. Similar results were obtained in independent experiments (Figure S10C).536 Cell Stem Cell 5, 527–539, November 6, 2009 ª2009 Elsevier Inc.
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FoxO3 Regulates Neural Stem Cell Homeostasisto self-renewal defects and by the functional validation of direct
FoxO targets in NSCs (Paik et al., 2009). FoxO factors may in
fact provide a pivotal link between extrinsic and intrinsic signals
by integrating a variety of external stimuli, including growth
factors and oxidative stress (Salih and Brunet, 2008).
FoxO factors are necessary for the maintenance and self-
renewal of adult hematopoietic stem cells (HSCs) (Miyamoto
et al., 2007; Tothova et al., 2007). HSCs continuously regen-
erate the hematopoietic tissue whereas NSCs have lower
regenerative capacity. Interestingly, the program of genes
controlled by FoxO3 in NSCs reveals little overlap with the
program of genes controlled by FoxO factors in HSCs (Miya-
moto et al., 2007; Tothova et al., 2007). FoxO factors may regu-
late different stem cell types by inducing specific gene expres-
sion programs tailored for the unique biology of these types of
stem cells. Identifying the programs induced by FoxO3 in
different types of stem cells should help uncover differences
between stem cells from rapidly regenerating versus slowly re-
generating tissues.
FoxO factors are inhibited by the PI3K-Akt pathway and acti-
vated by the PTEN phosphatase. Increased PI3K-Akt signaling
promotes the self-renewal of cortical progenitors and adult
SVZ cells (Groszer et al., 2006; Li et al., 2002; Sinor and Lillien,
2004). Whether increased PI3K-Akt signaling promotes the
short-term expansion of progenitors at the expense of the NSC
pool in vivo is unknown. The deletion of the PTEN gene in
HSCs leads to the long-term depletion of HSCs, which is
rescued by rapamycin, an mTOR inhibitor (Yilmaz et al., 2006).
It will be interesting to determine the importance of the PI3K-
Akt pathway and downstream pathways (FoxO versus mTOR)
in the long-term regulation of the NSC pool.
Our findings suggest that FoxO3 is necessary for the expres-
sion of hypoxia-dependent genes in NSCs, several of which
are known to be targets of the hypoxia-inducible factor HIF1.
In C. elegans, the FoxO transcription factor DAF-16 and HIF1
also share common target genes (McElwee et al., 2004).
However, in other mammalian cells, FoxO3 inhibits hypoxia-
dependent genes in an indirect manner (Bakker et al., 2007;
Emerling et al., 2008). Thus, FoxO3 may both directly regulate
some HIF1 target genes and indirectly inhibit HIF1-dependent
transcription. The balance between these two functions of
FoxO3 could be altered by variations in the levels of oxygen.
Alternatively, the regulation of the hypoxic program may differ,
depending on the types of cells or tissues. The finding that
FoxO3 is required for the expression of genes that mediate the
response to hypoxia in NSCs is consistent with the observation
that hypoxia and HIF1 promote self-renewal and multipotency
in stem cells (Keith and Simon, 2007). NSCs are located in close
proximity to blood vessels in vivo and may be subjected to
varying levels of oxygen (Mirzadeh et al., 2008; Shen et al.,
2008; Tavazoie et al., 2008), so the ability of FoxO3 to regulate
oxygen metabolism in NSCs might also play a role in the protec-
tion of these cells in vivo.CIn conclusion, our findings suggest that a gene identified
based on its function in regulating lifespan in invertebrates may
have evolved to play a critical role in regulating NSC homeostasis
in mammals. Because NSCs have been shown to be important
for learning, memory, and mood regulation, our findings could
give insight into the decline in cognitive function that occurs
during aging.
EXPERIMENTAL PROCEDURES
Materials and other experimental procedures are described in the Supple-
mental Data.
Animals
FoxO3/ and FoxO3lox/lox mice in the FVB/N background were generously
provided by Dr. Ron DePinho (Dana Farber Cancer, Boston). Nestin-Cre
mice in the C57/Bl6 background were purchased from Jackson Laboratories.
All care and procedures were in accordance with the Guide for the Care and
Use of Laboratory Animals. All animal experiments were approved by Stan-
ford’s Administrative Panel on Laboratory Animal Care (APLAC) and in accor-
dance with institutional and national guidelines.
Quantification of BrdU-Positive NSCs and Progenitors In Vivo
Mice were injected intraperitoneally with 50 mg/kg of BrdU (EMD Biosciences)
once a day for 7 days and sacrificed either 1 day or 1 month later. Mice were
anesthetized and perfused transcardially with PBS containing 5 U/ml of
heparin, then with 4% paraformaldehyde (PFA). Brains were fixed in 4% PFA
for 4 hr at 4C, then in 30% sucrose/4% PFA overnight at 4C, and embedded
in Tissue-Tek (Sakura) at 80C. Coronal sections (40 mm) were cut with
a microtome. Sections were incubated in 3% H2O2 for 30 min, in 2 N HCl solu-
tion for 30 min at 37C, followed by washes in boric acid buffer (pH 8.4).
Sections were incubated with the BrdU antibody (AbD serotec, 1:500) over-
night at 4C, and then with the secondary antibody (biotinylated donkey
anti-rat, Jackson ImmunoResearch, 1:500) overnight at 4C. The sections
were then incubated in the ABC solution (Vector Laboratories) for 90 min,
and with DAB (Sigma, 0.05%) containing 0.15% H2O2 for 2–10 min. The
sections were dried, dehydrated on slides, and mounted with Permount
(Fisher Scientific). BrdU staining and quantification was performed on every
sixth section from Bregma +1.54 mm to 1.34 mm (SVZ) and from Bregma
0.94 mm to 3.88 mm (DG). BrdU-positive cells were counted in a blinded
manner. The total number of BrdU-positive cells in each region was obtained
by multiplying the number of BrdU-positive nuclei by 6. In the DG, the number
of BrdU-positive cells was normalized by the granular cell layer (GCL) volume
(in mm3). The GCL volume was quantified on every sixth section by calculating
the area of the GCL on both sides via Metamorph (Molecular Devices). The
total GCL volume was estimated by multiplying these areas by 6 and then
by 40 mm.
Mouse NSC Cultures
Isolation of mouse NSCs/progenitors was done as described previously
(Palmer et al., 1997). In brief, the brains were dissected to remove the olfactory
bulbs, cerebellum, and brainstem. The forebrains were finely minced; digested
for 30 min at 37C in HBSS media containing 2.5 U/ml Papain (Worthington),
1 U/ml Dispase (Roche), and 250 U/ml DNase I (Sigma); and mechanically
dissociated. NSCs/progenitors were purified with two Percoll gradients
(25% then 65%) (Amersham) and plated at a density of 105 cells/cm2 in Neuro-
Basal-A medium with penicillin-streptomycin-glutamine (Invitrogen), B27
supplement (Invitrogen, 2%), bFGF (Peprotech, 20 ng/ml), and EGF (Pepro-
tech, 20 ng/ml) (self-renewal/proliferation media). Cells were incubated at
37C in 5% CO2 and 20% oxygen at 95% humidity.(E) FoxO3/ NSCs form fewer neurospheres than FoxO3+/+ NSCs in low-oxygen conditions. Normalized frequency of neurospheres formed from NSCs at low
density in 20% oxygen (20) or in 2% oxygen (2). NSCs were dissociated from secondary neurospheres generated from 3-month-old FoxO3/ and FoxO3+/+
mice. Values represent mean ± SEM from four independent experiments with three to five littermates for each genotype. The normalization was done by dividing
the triplicate average from each experiment in 2% oxygen by the triplicate average from the same experiment in 20% oxygen. Two-way ANOVA, Bonferroni post-
tests, *p < 0.05; **p < 0.01.ell Stem Cell 5, 527–539, November 6, 2009 ª2009 Elsevier Inc. 537
Cell Stem Cell
FoxO3 Regulates Neural Stem Cell HomeostasisPrimary and Secondary Neurosphere Assays
At isolation, NSCs were plated in triplicate at low density (1 to 32,000 cells/ml)
into a 24-well plate in self-renewal/proliferation media and the number of
primary neurospheres formed was assessed in a blinded manner after
7 days. Primary neurospheres were dissociated with Accutase (Chemicon)
and plated in triplicate at low density (1 to 4000 cells/ml) into a 24-well plate
in self-renewal/proliferation media and the number of secondary neurospheres
formed was assessed after 7 days. For moderate hypoxia (2%), cell culture
dishes were placed into an Invivo2 humidified hypoxia workstation (Ruskinn
Technologies, Bridgend, UK).
NSC Ability to Generate Different Neural Lineages
Secondary neurospheres from self-renewal assays were plated onto acid-
treated glass coverslips (Bellco) coated with poly-D-lysine (Sigma, 50 mg/ml)
and incubated in differentiation media (NeuroBasal-A medium supplemented
with penicillin-streptomycin-glutamine, B27 supplement, and 1% fetal bovine
serum [Invitrogen]). Differentiated neurospheres were fixed in 4% PFA and
then stained with antibodies to Tuj1 (Covance, 1:1000) or to GFAP (guinea
pig, Advanced Immunochemicals Inc., 1:1000). Alternatively, neurospheres
were incubated with the antibody to O4 (a gift from Ben Barres, 1:1 in 10%
goat serum/1% BSA/0.1 M L-lysine) before fixation. Secondary antibodies
(Molecular Probes) were used at a dilution of 1:400. For quantification, three
coverslips containing 50 whole neurospheres per coverslip were counted in
a blinded manner.
Microarray Analysis
FoxO3/ and FoxO3+/+ secondary neurospheres were collected 6 days after
initial plating at 53 104 cells/ml. Total RNA was extracted with the mirVana kit
(Ambion). Microarray hybridization was performed at the Stanford Protein and
Nucleic Acid facility with oligonucleotide arrays (Affymetrix, Mouse Genome
430 2.0 Array). Background adjustment and normalization with RMA (robust
multiarray analysis) was performed. The RankProd implementation of the
method of Rank Products was used to determine the differentially expressed
probes.
ACCESSION NUMBERS
Microarray data were deposited at the Gene Expression Omnibus (GEO)
database under the accession number GSE18326.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures,
10 figures, and 1 table and can be found with this article online at http://
www.cell.com/immunity/supplemental/S1934-5909(09)00510-4.
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